Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2 CAD | -4.76% | -20.00% | +37.93% |
Business Summary
Number of employees: 7
Sales per Business
CAD in Million | 2024 | Weight | Delta |
---|---|---|---|
Pharmaceutical
100.0
%
| 2 | 100.0 % | - |
Sales per region
CAD in Million | 2024 | Weight | Delta |
---|---|---|---|
Canada
100.0
%
| 2 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Luc Grégoire
CEO | Chief Executive Officer | 64 | 23-03-16 |
Colette Laurin
DFI | Director of Finance/CFO | - | 15-12-27 |
Pascal Brabant
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
André Boulet
CTO | Chief Tech/Sci/R&D Officer | - | 15-03-26 |
Nathalie Boucher
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
André Boulet
CTO | Chief Tech/Sci/R&D Officer | - | 15-03-26 |
Luc Grégoire
CEO | Chief Executive Officer | 64 | 23-03-16 |
Kathryn Gregory
BRD | Director/Board Member | 62 | 02-27 |
Jean Forcione
BRD | Director/Board Member | 58 | 23-05-11 |
David Baker
CHM | Chairman | 60 | 23-05-11 |
Louis Flamand
BRD | Director/Board Member | - | 17-05-24 |
Edouard Dahl
BRD | Director/Board Member | - | 23-05-11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 148,222,531 | 127,172,676 ( 85.80 %) | 0 | 85.80 % |
Company contact information
Devonian Health Group, Inc.
360, rue des Entrepreneurs
G5V 4T1, Montmagny
+
http://www.groupedevonian.comSector
1st Jan change | Capi. | |
---|---|---|
+37.93% | 21.7M | |
+29.43% | 684B | |
+30.05% | 568B | |
-4.04% | 361B | |
+18.42% | 329B | |
+4.88% | 284B | |
+15.98% | 240B | |
+9.52% | 208B | |
-6.83% | 200B | |
+8.05% | 166B |
- Stock Market
- Equities
- GSD Stock
- Company Devonian Health Group Inc.